Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DK047186-03
Application #
2146524
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1994-08-01
Project End
1999-07-31
Budget Start
1996-08-20
Budget End
1997-07-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215

  Publications

Nucera, Carmelo; Nehs, Matthew A; Nagarkatti, Sushruta S et al. (2011) Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist 16:296-309
Archer, S; Meng, S; Wu, J et al. (1998) Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery 124:248-53